Boston Scientific(US:BSX) Globenewswire·2026-03-12 12:24Core Viewpoint - Boston Scientific Corporation is facing a securities fraud class action lawsuit, with a deadline for investors to act by May 4, 2026 [1][3][4]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased or acquired Boston Scientific common stock between July 23, 2025, and February 3, 2026 [4]. - The allegations include violations of the Securities Exchange Act of 1934, specifically concerning misrepresentations about Boston Scientific's U.S. electrophysiology segment [4]. Group 2: Investor Actions - Investors who wish to serve as lead plaintiffs must file necessary documents by May 4, 2026, although participation in any recovery does not require serving as a lead plaintiff [3]. - Shareholders are not required to pay any fees or expenses as all representation is on a contingency fee basis [3]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since its inception in 1993 and has a strong track record in class action litigation [5]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [5].